Navigation Links
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx
Date:7/16/2014

ploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological disorders, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO®, in the United States and other countries for the treatment of patients with homozygous FH.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding Isis' strategic alliance with GSK, and the development, activity, therapeutic and commercial potential and safety of ISIS-TTRRx.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  The
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014  NuView Life Sciences, Inc. (NuView) ... collaboration agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) ... diagnostic biomarker to detect cancers of the breast ... future diagnostic-imaging applications. NuView retains all rights for ... in-vitro urine screen applications. Under the ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014 ... announced that it has earned a $4 million ... AKAO ) associated with the initiation of a ... serious multi-drug resistant (MDR), gram-negative bacterial infections.  The ... study to evaluate the efficacy and safety of ...
(Date:9/17/2014)...  Trovagene, Inc., (NASDAQ:   TROV) a developer of ... , Ph.D., has joined the Company,s Scientific Advisory Board. ... in the kinase genes that are associated with colorectal ... Department of Oncology, Torino Medical School, Institute for Cancer ... "Alberto,s work in cancer genomics has had ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 2Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 3
(Date:9/17/2014)... now no one can say whether yoga provides clinical ... new article in the Journal of Psychiatric Practice ... of people with the condition who practice yoga. What ... a substantial help, but it sometimes carries risks, too. ... for bipolar disorder," said lead author Lisa Uebelacker, associate ...
(Date:9/17/2014)... 17, 2014 With the development ... functions of adjusting human body physiology, preventing diseases, ... popularity with a variety of specific populations. In ... China reached RMB187.4 billion, up 12.0% year on ... , China's health product industry is composed of ...
(Date:9/17/2014)... 2014 A  recent news story ... man named Advait Thakur who had to stop attending ... disc disease. This disease led to a narrowing of ... and causing severe pain. Leading spine surgeon Dr. Todd ... can lead to such severe pain, as well as ...
(Date:9/17/2014)... U.S. News and World Report recently ... three mesothelioma treatment centers made the magazine’s list ... firm Baron and Budd reports. The ... MD Anderson Cancer Center and Brigham and Women’s ... ) , U.S. News and World Report looked ...
(Date:9/17/2014)... IL (PRWEB) September 17, 2014 The disability ... lead a three-day protest vigil against the World Federation of ... held in Chicago. The American group Final Exit Network is ... Embassy Suites Chicago. The group has scheduled a rally to ... September 18 at 12 PM. , ”We are here to ...
Breaking Medicine News(10 mins):Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Disability Rights Activists to Protest International Euthanasia Group Meeting in Chicago 2
... Treatment of wounds and wound healing has always been difficult ... about these processes and understanding inter cellular mechanisms is the ... Researchers led by Vito ... found that integrin-a protein that helps trigger the healing process ...
... in plants, has been pin pointed in humans as being responsible ... chances of developing an inherited form of the diseases increases by ... chromosome 16. , The ... USA. The complete data will appear in the May 31st issue ...
... a break through in ENT surgery by conducting the first ... the transplant is not able to speak with a perfectly ... accident. He had been unable to speak normally for 20 ... other patients and support groups. , ...
... era of fighting battle against cancer, researchers of Virginia ... the destiny. Radiation therapy is used to treat many ... makes cancer cells more susceptible to radiation therapy. ... cells, it has unwanted side effects that could counter ...
... within a short time are more prone to depression. ... Center, doing a research on depression found that people with ... depression are twice as likely to get depressed than the ... five stages of sleep that we cycle through several times ...
... size of children's tummies may offer a simple method of ... diabetes at a later age.Among adults, fat around the waist ... studies suggest that it is a better indicator of risk ... ,A large waist is said to be associated ...
Cached Medicine News:Health News:Gene enchances radiation therapy - A novel approach to fight cancer 2
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
Medicine Products: